Search results
Results from the WOW.Com Content Network
Retinal detachment is a condition where the retina pulls away from the tissue underneath it. [1] [2] [3] It may start in a small area, but without quick treatment, it can spread across the entire retina, leading to serious vision loss and possibly blindness. [4] Retinal detachment is a medical emergency that requires surgery. [2] [3]
Intravitreal injection is the method of administration of drugs into the eye by injection with a fine needle. The medication will be directly applied into the vitreous humor. [1] It is used to treat various eye diseases, such as age-related macular degeneration (AMD), diabetic retinopathy, and infections inside the eye such as endophthalmitis. [1]
General sales list Gutt/g Guttae (drops) Meds Medications Nocte/QHS At night Occ Ointment od/QD Once a day otc Over the counter (bought medication) P Pharmacy (drug) POM Prescription-only medicine prn When required q Every (e.g. q2h – every two hours) qds/qid Four times a day Rx Prescription tds/tid Three times a day ung Ointment
In its most severe form, ROP causes retinal detachment, with attendant visual loss. Treatment is aimed mainly at prevention, via laser or Avastin therapy. Stargardt's disease; Uveitis: is a group of 30 intraocular inflammatory diseases [70] caused by infections, systemic diseases, organ-specific autoimmune processes, cancer or trauma. [71]
Surgically correct retinal detachment by scleral buckle or pars plana vitrectomy. [1] Prior to surgery, oral or topical anti glaucoma drugs may be used to reduce IOP. [1] After surgical correction of the retinal detachment, the condition resolves, aqueous cells disappear and IOP normalizes. [3] The condition is not responsive to corticosteroid ...
A retinal tuft is a gliotic degeneration of the retina composed of focal adhesions in the extracellular matrix joining the retina and the posterior hyaloid of the eye. [4] [5] Retinal tufts are a common lesion of the retina and under 1% of these tufts are thought to lead to retinal detachment.
Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment created from the same parent mouse antibody as bevacizumab.It is an anti-angiogenic [16] that is approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion.
Diabetic retinopathy (also known as diabetic eye disease) is a medical condition in which damage occurs to the retina due to diabetes.It is a leading cause of blindness in developed countries and one of the lead causes of sight loss in the world, even though there are many new therapies and improved treatments for helping people live with diabetes.